dalbavancin

Durata's anti-infective drug shows efficacy, safety -FDA panel
Yahoo/Zacks.com
Mon, 03/31/14 - 04:39 pm
Durata
FDA
advisory panels
dalbavancin
3 Upcoming FDA Meetings You Should be Watching
Motley Fool
Sun, 03/23/14 - 09:45 am
EXACT Sciences
Cologuard
Pfizer
dalbavancin
Cubist Pharmaceuticals
tedizolid phosphate
3 Biotechs With Major Catalysts Incoming
Motley Fool
Wed, 03/19/14 - 11:22 am
dalbavancin
Durata Therapeutics
MannKind
Afrezza
Cologuard
EXACT Sciences
Durata Therapeutics presents new efficacy review of dalbavancin
The Fly on the Wall
Wed, 10/2/13 - 09:33 am
Durata Therapeutics
dalbavancin
skin infections
Durata, with license to Pfizer drug, lays plans for $86M IPO
Fierce Biotech
Fri, 03/23/12 - 12:45 pm
Durata
Pfizer
IPOs
dalbavancin